95 related articles for article (PubMed ID: 7678714)
1. Fazarabine: a report of response in a patient with multiply relapsed embryonal cell carcinoma.
Johnston PG; Kleiner D; Cowan KH
Am J Clin Oncol; 1993 Feb; 16(1):34-7. PubMed ID: 7678714
[TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor.
Goldberg RM; Reid JM; Ames MM; Sloan JA; Rubin J; Erlichman C; Kuffel MJ; Fitch TR
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2363-70. PubMed ID: 9815635
[TBL] [Abstract][Full Text] [Related]
3. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.
Einhorn LH; Brames MJ; Heinrich MC; Corless CL; Madani A
Am J Clin Oncol; 2006 Feb; 29(1):12-3. PubMed ID: 16462496
[TBL] [Abstract][Full Text] [Related]
5. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
6. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
7. Activity of thalidomide in patients with platinum-refractory germ-cell tumours.
Rick O; Braun T; Siegert W; Beyer J
Eur J Cancer; 2006 Aug; 42(12):1775-9. PubMed ID: 16765039
[TBL] [Abstract][Full Text] [Related]
8. Testicular seminoma occurring 8 years after treatment of a metastatic extragonadal germ cell tumor.
Ando R; Yasui T; Tozawa K; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2007 Jan; 14(1):85-6. PubMed ID: 17199868
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.
Cavalli F; Klepp O; Hansen H; Rozencweig M
Cancer Treat Rep; 1983 Oct; 67(10):953-4. PubMed ID: 6313188
[No Abstract] [Full Text] [Related]
10. Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer.
Ondrus D; Hornák M; Matoska J
Neoplasma; 1993; 40(3):189-92. PubMed ID: 7688871
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.
Walters RS; Theriault RL; Holmes FA; Hortobagyi GN; Esparza L
Invest New Drugs; 1992 Apr; 10(1):43-4. PubMed ID: 1376723
[TBL] [Abstract][Full Text] [Related]
13. Isolated solitary bony metastasis of a nonseminomatous germ cell tumor.
Aldejmah A; Soulières D; Saad F
Can J Urol; 2007 Feb; 14(1):3458-60. PubMed ID: 17324327
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.
Driscoll JS; Johns DG; Plowman J
Invest New Drugs; 1985; 3(4):331-4. PubMed ID: 2417984
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment of metastatic germ cell cancers].
Timsit MO; Lebret T; Lugagne PM; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S376-81. PubMed ID: 19070818
[TBL] [Abstract][Full Text] [Related]
16. Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Beer TM; Tangen CM; Nichols CR; Margolin KA; Dreicer R; Stephenson WT; Quinn DI; Raghavan D; Crawford ED
Cancer; 2006 Jun; 106(12):2624-9. PubMed ID: 16688776
[TBL] [Abstract][Full Text] [Related]
17. Is the blood-brain barrier relevant in metastatic germ cell tumor?
Azar JM; Schneider BP; Einhorn LH
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):163-6. PubMed ID: 17707269
[TBL] [Abstract][Full Text] [Related]
18. Current concepts in risk factor assessment for advanced germ cell cancer.
Garzotto M; Nichols CR
Semin Urol Oncol; 2001 Aug; 19(3):165-9. PubMed ID: 11561983
[TBL] [Abstract][Full Text] [Related]
19. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
Marwaha S; Venner PM; North SA
Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
[TBL] [Abstract][Full Text] [Related]
20. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
